- Home
- GDYN vs KURA Comparison
GDYN vs KURA Comparison
Compare GDYN & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDYN
- KURA
- Stock Information
- Founded
- GDYN 2006
- KURA 2014
- Country
- GDYN United States
- KURA United States
- Employees
- GDYN N/A
- KURA N/A
- Industry
- GDYN Computer Software: Prepackaged Software
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GDYN Technology
- KURA Health Care
- Exchange
- GDYN Nasdaq
- KURA Nasdaq
- Market Cap
- GDYN 1.4B
- KURA 1.3B
- IPO Year
- GDYN N/A
- KURA N/A
- Fundamental
- Price
- GDYN $17.71
- KURA $10.06
- Analyst Decision
- GDYN Strong Buy
- KURA Strong Buy
- Analyst Count
- GDYN 7
- KURA 9
- Target Price
- GDYN $17.43
- KURA $30.29
- AVG Volume (30 Days)
- GDYN 806.1K
- KURA 1.4M
- Earning Date
- GDYN 10-31-2024
- KURA 11-07-2024
- Dividend Yield
- GDYN N/A
- KURA N/A
- EPS Growth
- GDYN N/A
- KURA N/A
- EPS
- GDYN 0.03
- KURA N/A
- Revenue
- GDYN $328,358,000.00
- KURA N/A
- Revenue This Year
- GDYN $11.88
- KURA N/A
- Revenue Next Year
- GDYN $18.30
- KURA N/A
- P/E Ratio
- GDYN $592.63
- KURA N/A
- Revenue Growth
- GDYN 4.10
- KURA N/A
- 52 Week Low
- GDYN $9.07
- KURA $9.06
- 52 Week High
- GDYN $19.86
- KURA $24.17
- Technical
- Relative Strength Index (RSI)
- GDYN 58.80
- KURA 15.94
- Support Level
- GDYN $15.63
- KURA $15.55
- Resistance Level
- GDYN $19.86
- KURA $16.68
- Average True Range (ATR)
- GDYN 0.93
- KURA 1.16
- MACD
- GDYN -0.12
- KURA -0.50
- Stochastic Oscillator
- GDYN 53.56
- KURA 3.78
About GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc provides enterprise-level digital transformation in the areas of search, analytics, and release automation to Fortune 1000 companies. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.